Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides
Condition(s):LymphomaLast Updated:July 9, 2018Terminated
Hide Studies Not Open or Pending
Condition(s):LymphomaLast Updated:July 9, 2018Terminated
Condition(s):Sezary Syndrome; Mycosis FungoidesLast Updated:November 22, 2023Recruiting
Condition(s):Hematologic Malignancy; Refractory LymphomaLast Updated:January 20, 2021Not yet recruiting
Condition(s):Sezary Syndrome; PruritusLast Updated:May 10, 2017Terminated
Condition(s):Mycosis Fungoides; Sezary Syndrome; Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8; Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8; Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8; Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8; Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8; Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v8; Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v8; Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8; Stage IVA1 Mycosis Fungoides and Sezary Syndrome AJCC v8; Stage IVA2 Mycosis Fungoides and Sezary Syndrome AJCC v8; Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v8Last Updated:September 5, 2023Active, not recruiting
Condition(s):Mycosis Fungoides; Lymphomatoid Papulosis; Sezary SyndromeLast Updated:December 13, 2023Recruiting
Condition(s):B-cell LymphomaLast Updated:March 21, 2024Not yet recruiting
Condition(s):Adult T-cell Leukemia-LymphomaLast Updated:March 30, 2017Completed
Condition(s):B-NHL; B-Non Hodgkin Lymphoma; Acute Lymphocytic Leukemia; Acute Lymphoblastic Leukemia; B-precursor ALL; B-All; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, B Cell; B-Cell Lymphoma; B-Cell Leukemia; Acute Lymphoid LeukemiaLast Updated:January 26, 2024Recruiting
Condition(s):Peripheral T/NK Cell Lymphoma (R/R PTCL)Last Updated:October 21, 2022Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.